Durability of apremilast response through 5 years of treatment in subjects with psoriatic arthritis

Conference contribution


Publication Details

Author(s): Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, Pari M, Teng L, Wollenhaupt J
Publication year: 2018
Volume: 79
Journal issue: 3
Pages range: AB114-AB114
ISSN: 0190-9622


FAU Authors / FAU Editors

Schett, Georg Prof. Dr. med.
Lehrstuhl für Innere Medizin III


External institutions with authors

Celgene Corporation
Monash University
Schön Klinik Hamburg Eilbek
Swedish Medical Center
Toronto Western Hospital
University of California, San Diego
University of Orléans / Université d'Orléans


How to cite

APA:
Kavanaugh, A., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Lespessailles, E., Mease, P.J.,... Wollenhaupt, J. (2018). Durability of apremilast response through 5 years of treatment in subjects with psoriatic arthritis. (pp. AB114-AB114).

MLA:
Kavanaugh, Arthur, et al. "Durability of apremilast response through 5 years of treatment in subjects with psoriatic arthritis." 2018. AB114-AB114.

BibTeX: 

Last updated on 2019-28-01 at 08:53